Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1825-1830

  Volpato, Stefano ^a   Vigna, Giovanni B ^a   McDermott, Mary M ^b   Cavalieri, Margherita ^a   Maraldi, Cinzia ^a   Lauretani, Fulvio ^c   Bandinelli, Stefania ^d   Zuliani, Giovanni ^a   Guralnik, Jack M ^e   Fellin, Renato ^a   Ferrucci, Luigi ^e  

^a UNIVERSITY OF FERRARA   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d Azienda Sanitaria di Firenze   (Italy)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; ITALY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SENESCENCE;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION; ITALY; LIPOPROTEIN(A); MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TIBIAL ARTERIES; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER; URBAN POPULATION;

EID: 77953121659     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.370     Document Type: Article

References (29)

1. Danesh J., Collins R., and Peto R. Lipoprotein[a] and coronary heart disease. Meta-analysis of prospective studies. Circulation 102 (2000) 1082-1085
2. Bennet A., Di Angelantonio E., Erqou S., Eiriksdottir G., Sigurdsson G., Woodward M., Rumley A., Lowe G.D., Danesh J., and Gudnason V. Lipoprotein[a] levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 168 (2008) 598-608
3. Smolders B., Lemmens R., and Thijs V. Lipoprotein [a] and stroke: a meta-analysis of observational studies. Stroke 38 (2007) 1959-1966
4. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein[a], and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
5. Aboyans V., Criqui M.H., Denenberg J.O., Knoke J.D., Ridker P.M., and Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 (2006) 2623-2629
6. Sandholzer C., Hallman D.M., Saha N., Sigurdsson G., Lackner C., Csaszar A., Boerwinkle E., and Utermann G. Effects of the apolipoprotein[a] size polymorphism on the lipoprotein[a] concentration in 7 ethnic groups. Hum Genet 86 (1991) 607-614
7. Vigna G.B., Bolzan M., Romagnoni F., Valerio G., Vitale E., Zuliani G., and Fellin R. Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation 85 (1992) 2205-2211
8. Brevetti G., Oliva G., Silvestro A., Scopacasa F., and Chiariello M. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 175 (2004) 131-138
9. Tsimikas S., Kiechl S., Willeit J., Mayr M., Miller E.R., Kronenberg F., Xu Q., Bergmark C., Weger S., Oberhollenzer F., and Witztum J.L. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. J Am Coll Cardiol 6 (2006) 2219-2228
10. Tsimikas S., Tsironis L.D., and Tselepis A.D. New insights into the role of lipoprotein[a]-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 27 (2007) 2094-2099
11. Koschinsky M.L., and Marcovina S.M. Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity. Curr Opin Lipidol 15 (2004) 167-174
12. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the national Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
13. McDermott M.M., Liu K., Guralnik J.M., Ferrucci L., Green D., Greenland P., Tian L., Criqui M.H., Lo C., Rifai N., Ridker P.M., Zheng J., and Pearce W. Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. J Gerontol A Biol Sci Med Sci 61 (2006) 374-379
14. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., Harris T.B., and Guralnik J.M. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48 (2000) 1618-1625
15. McDermott M.M., Guralnik J.M., Albay M., Bandinelli S., Miniati B., and Ferrucci L. Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI study. J Am Geriatr Soc 52 (2004) 405-410
16. McDermott M.M., Fried L., Simonsick E., Ling S., and Guralnik J.M. Peripheral arterial disease is independently associated with impaired lower extremity functioning: the Women's Health and Aging Study. Circulation 101 (2000) 1007-1012
17. Marz W., Siekmeier R., and Kostner G.M. Determination of lipoprotein(a): evaluation of three methods. Eur J Clin Chem Clin Biochem 31 (1993) 295-301
18. Kaaks R., and Riboli E. Validation and calibration of dietary intake measurements in the EPIC project: methodological considerations. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 (1997) S15-S25
19. Patel K.V., Coppin A.K., Manini T.M., Lauretani F., Bandinelli S., Ferrucci L., and Guralnik J.M. Midlife physical activity and mobility in older age: the InCHIANTI study. Am J Prev Med 31 (2006) 217-224
20. Fried L.P., Kasper J.D., Guralnik J.M., and Simonsick E.M. Introduction. In: Guralnik J.M., Fried L.P., Simonsick E.M., Kasper J.D., and Lafferty M.E. (Eds). The Women's Health and Aging Study: Health and Social Characteristics of Older Women With Disability (1995), National Institute on Aging, Bethesda, MD 1-8 NIH Publication 95-4009
21. McDermott M.M., Guralnik J.M., Corsi A., Albay M., Macchi C., Bandinelli S., and Ferrucci L. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 150 (2005) 276-281
22. Krsukal W.H., and Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47 (1952) 583-621
23. O'Neal D.N., Lewicki J., Ansari M.Z., Matthews P.G., and Best J.D. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis 136 (1998) 1-8
24. Khawaja F.J., Bailey K.R., Turner S.T., Kardia S.L., Mosley Jr. T.H., and Kullo I.J. Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations. Mayo Clin Proc 82 (2007) 709-716
25. Tseng C.H. Lipoprotein[a] is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan. Diabetes Care 27 (2004) 517-521
26. Pradhan A.D., Shrivastava S., Cook N.R., Rifai N., Creager M.A., and Ridker P.M. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation 117 (2008) 823-831
27. Maeda S., Abe A., Seishima M., Makino K., Noma A., and Kawade M. Transient changes of serum lipoprotein[a] as an acute phase protein. Atherosclerosis 78 (1989) 145-150
28. Ramharack R., Barkalow D., and Spahr M.A. Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein[a] and apolipoprotein[a] mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 18 (1998) 984-990
29. Carantoni M., Zuliani G., Bader G., Palmieri E., Volpato S., Passaro A., Imbastaro T., Mezzetti A., and Fellin R. Low density lipoprotein cholesterol, lipoprotein[a], and apo[a] isoforms in the elderly: relationship to fasting insulin. Nutr Metab Cardiovasc Dis 9 (1999) 228-233